8
after 8-10 hours of transfection and cells were allowed to grow in complete media. siRNA oligos were 225 purchased from Eurogentec (Seraing, Belgium) along with control siRNA (SR-CL000-005). The sequences of 226 siRNAs as follows: RNF167_1, 5' AAG CAG AGG GAC UGG GUC UUU 3'; RNF167_2, 5' GGG ACU 227 GGG UCU UCA CUU CUU. Cells were either treated with acetate Ringer's solution (10 mM Glucose, 70 mM 228 Sodium acetate, 5mM KCl, 80 mM NaCl, 2mM NaH 2 PO 4 , 2mM CaCl 2 , 1mM MgCl 2 , and 10 mM HEPES, final 229 pH 6.9) for two hours (32) or harvested after 24 hours of transfection for immunostaining and qRT-PCR 230 respectively.
232
Immunofluorescence and Confocal microscopy 233 HeLa cells were transfected with RNF167 constructs as mentioned in the figure legends. Briefly, cells were 234 transfected at 18-20 hours of plating (~60% confluency) using Lipofectamine 3000. Post transfection (24 235 hours), cells were treated with acetate Ringer's solution (pH 6.9) for two hours. Cells were fixed in 4% PFA in 236 PHEM buffer (60 mM Pipes, 10 mM EGTA, 25 mM HEPES, and 2 mM MgCl2, final pH 6.8). Immunostaining 237 was performed as previously described (32) . Briefly, cells were permeabilized in blocking solution (0.2% 238 saponin + 5% FBS in PHEM buffer) for 30 minutes. Cells were washed in 1X PBS, followed by one-hour 239 incubation with the primary antibody in staining buffer (0.2% saponin in PHEM buffer). These cells were 240 further incubated with a secondary antibody in the staining buffer for 30 minutes. Cells were washed in 1X PBS 241 to remove unbounded antibodies and nuclear staining was performed using 10 μg/ml DAPI for one minute, To detect the luminal part of LAMP1 in the plasma membrane, cells seeded on glass coverslips were treated 246 with acetate Ringer's solution (pH 6.9) for two hours. These cells were either treated with DMSO or 5μM 247 ionomycin for 10 minutes and then immediately transferred on to the ice. Immunostaining was performed as 248 previously described (18) . Briefly, cells were incubated with anti-LAMP1 (mouse, 1:50) for 30 minutes, 4°C, 249 followed by fixation using 4% PFA in 1X PBS for 10 minutes and incubation with secondary antibody (1:1000) 250 for 1 hour. Next, the cells were stained with 10 μg/ml DAPI and mounted in ProLong Gold antifade reagent. 260 Lysosomal distribution was calculated in terms of the perinuclear index (PNI) (32). Briefly, average LAMP1 261 intensities were calculated from the whole cell (I total ), within 5µm distance from the nuclear surface (I perinuclear ) 262 and more than 10 µm distance from the nuclear surface (I peripheral ). These intensities were normalized as I <5 = (I 263 perinuclear / I total )-100 and I >10 = (I peripheral / I total )-100 and the PNI was calculated as the difference between I <5 and 264 I >10 (PNI= I <5 -I >10 ).
Quantification of lysosomal distribution and Colocalization analysis

265
Line Profiling: Line profiling was performed as described earlier (33). The average intensity of LAMP1 positive 266 vesicles was calculated from three independent lines drawn from the nuclear surface. For all three lines, 267 intensities were grouped into three categories, <5µm, 5-15 µm, and >15µm and fractional intensities of each of 268 these regions were calculated using total intensity of that particular line. These fractional values were plotted 269 against the distance from the nuclear surface. Plasma membrane repair assays 275 Plasma membrane repair assays were performed as described earlier (34, 35) and listed below.
276
Immunofluorescence: HeLa cells stably expressing empty vector, RNF167 WT and variants were treated with 277 acetate Ringer's solution (pH 6.9) for two hours. Cells were washed with ice-cold HBSS thrice and followed by 278 200 ng/ml Streptolysin-O (SLO) treatment for five minutes on ice. SLO containing buffer was replaced with 279 HBSS or HBSS containing 4 mM CaCl 2 at 37 ο C to allow plasma membrane resealing and incubated further for 280 10 min at 37 ο C. Next, nuclear staining was performed using 50 μg/ml propidium iodide (PI) for one minute 281 followed by three washes in HBSS at 37ᵒC. Cells were fixed in 4% PFA for 10 minutes. These cells were 282 further washed, incubated with 10 μg/ml DAPI and mounted in ProLong Gold antifade reagent. A minimum of 283 100 cells from each field was used for calculating the percentage of PI-positive cells in each group. 284 285 FACS analysis: HeLa cells stably expressing vector, RNF167 WT and other variants were treated as mentioned 286 above. After resealing, cells were trypsinized immediately. Cell pellets were washed with flow cytometer buffer 287 (1% FBS and 2mM EDTA in PBS) and resuspended it in 250 μl flow cytometer buffer. Before analysis on a BD 288 10 accuriC6 system (Beckman Coulter, Fullerton, CA, USA), cells were also stained with 50 μg/ml PI. At least 289 10,000 cells were used for analysis. The percentage of PMR was calculated as described earlier (35 performed in a total volume of 25 µl with 12.5 µl SYBER GREEN master mix (1725121, BioRad Laboratories, 296 Hercules, CA, USA), 1µl gene-specific primer mix, 5µl cDNA and 6.5 µl sterile water. GAPDH was used to 297 normalize the expression of RNF167 in all the samples used. The normalized values were expressed as relative 298 to control siRNA (considering mRNA level of RNF167 in control siRNA cells as 100%). The primers used for 299 quantitative PCR are listed below: Data were collected from at least three independent experiments and are shown as mean ± SEM. P values were 324 calculated using either two-tailed unpaired Student's t test (for two parameters) or one-way ANOVA or two-325 way ANOVA (for comparing multiple groups) followed by Tukey's test as mentioned in the figure legends with 326 significance levels set at α= 0.05. ns-not significant, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
327
All statistical analyses were performed in Graph Pad Prism 8 (Version 8.2.0). the possibility that this particular form may differ from the full-length RNF167 (RNF167-a) in its localization to 338 the membrane vesicles and lysosomal associated function ( Fig.1A) . To test such a possibility first we assessed 339 the expression of RNF167-b. Total RNA from multiple human cell lines were isolated and nested PCR using 340 primers to amplify amplicons of 334-bp and 138-bp for RNF167-a and RNF167-b isoforms was performed 341 ( Fig.1 B) . Strong band corresponding to 334-bp expected from the expression of RNF167-a was observed in all 342 the cells that were tested. However, some of the cell lines also resulted in an expected size of the 138-bp band, 343 representing the expression of RNF167-b. To confirm that the 138-bp fragment was indeed amplified from 344 RNF167-b, the DNA bands from colon cancer COLO 205 cell lines were extracted, sequenced and confirmed to 345 contain sequences corresponding to RNF167-b ( Fig.S1 .B). These results established the expression of a 346 RNF167 variant without a predicted signal sequence. To investigate the significance of putative SP, for subcellular localization of RNF167 and its function, we first were treated with acetate Ringer's solution (pH 6.9) and stained with anti-LAMP1 (a lysosomal marker) and 364 anti-GFP antibodies. We noted that consistent with its inability to localize to lysosomal compartments, cells 365 expressing RNF167-b showed substantially more dispersed lysosomes than those cells expressing RNF167-a 366 ( Fig. 1E ). To independently validate these findings, we assessed the distribution of lysosomes in cells by To determine the specificity of RNF167 mediated lysosomal positioning, we assessed the positioning of various 374 intracellular compartments like endosomes and mitochondria using organelle specific markers; EEA1 (early 375 endosomes), Rab11 (recycling endosomes), mTFP-lysosomes-20 (lysosomes) and MitoTracker Green 376 (mitochondria) in cells expressing RNF167-mRFP and treated with acetate Ringer's solution. Treatment of the 377 cells with acetate Ringer's solution is reported to affect mainly lysosomes, not other organelles (6). As 378 expected, we found that mTFP-lysosomes-20 accumulates in the perinuclear region of RNF167 expressing 379 cells, but the distribution of other organelles remains unaffected ( Fig. 2A ). Collectively these findings suggest 380 that RNF167 status might be a major modifier of lysosomal positioning which is important for various 381 physiological processes, such as repair of the damaged plasma membrane and cellular invasion (1). 382 383 13 RNF167 mediated lysosomal positioning is dependent on its E3 activity and localization to lysosomes 384 385 To establish that RNF167's localization to the lysosomal compartments is essential for lysosomal clustering, we 386 investigated the structure-function relationship of the PA domain in RNF167. To this end, we have examined 387 the lysosomal positioning in cells expressing RNF167ΔPA (Fig. 2B ), a domain reported to be essential for the To further demonstrate the role of RNF167, we next suppressed the levels of endogenous RNF167 in HeLa cells 397 using selective siRNAs designed to target two independent regions of 3'UTR in RNF167. Transfection of 398 specific siRNAs efficiently downregulated the expression of endogenous RNF167mRNA as compared to the 399 control siRNA (Fig.S1 .D). Lysosomal positioning in these cells were examined by immunostaining using anti-400 LAMP1 antibody and assessed in terms of PNI ( Fig. 3A-B ). In control siRNA transfected cells, the majority of 401 the lysosomes accumulated in the perinuclear region. Interestingly, depletion of endogenous RNF167 resulted 402 in the dispersal of LAMP1-positive compartments with a significant shift of lysosomes from the perinuclear 403 region to the periphery of the cells (Fig. 3A) , indicative of anterograde transport. As expected, the PNI of 404 specific siRNA transfected cells was significantly less as compared to the control siRNA treated cells ( Fig. 3B ).
405
To further corroborate the results, we assessed lysosomal distribution by line profiling as an established method 406 of choice (33). In control siRNA treated cells, lysosomes were dispersed throughout the cells with a significant 407 population at the perinuclear region (within 5µm distance from the nuclear surface). On the other hand, 408 RNF167 depletion resulted in an increased accumulation of lysosomes at the cell periphery which is defined as 409 more than 15µm from the nuclear surface ( Fig. 3C ). Collectively, these findings indicate the importance of 410 RNF167 in lysosomal positioning upon extracellular acidification. In mammalian cells, long-range transport of organelles is mediated by microtubule-based motor proteins, 415 including plus end-directed kinesins and minus end-directed dynein complexes (16) . Given that RNF167 416 promotes the accumulation of lysosomes towards the perinuclear region, we hypothesized that RNF167 417 mediated juxtanuclear positioning of lysosomes might be dynein dependent. To test this hypothesis, we 418 investigated the lysosomal positioning in HeLa cells transfected with RNF167 with or without p50-Dynamitin, 419 overexpression of which is known to disrupt the dynein-dynactin complex (31). As postulated, we found that in 420 RNF167 expressing cells the peripheral pool of LAMP1-positive vesicles is significantly increased in P50-
421
Dynamitin-GFP than GFP alone (Fig. 3D) . These observations suggest that RNF167 regulates lysosomal 422 positioning via dynein-dependent retrograde transport mechanism. To further validate the role of dynein motor 423 in this process, experiments were done in the presence of dynein inhibitor, Ciliobrevin D (37, 38). HeLa cells 424 transfected with RNF167 were treated with Ciliobrevin D for two hours before assaying for the lysosomal 425 clustering. We noticed that RNF167 could effectively cluster the lysosomes in the perinuclear region in control We investigated the involvement of RNF167 in lysosomal exocytosis caused by treatment with ionomycin, a 440 known enhancer of intracellular Ca 2+ level (35, 41) for 10 minutes after 2 hours of acetate Ringer's solution 441 treatment (pH 6.9). Exocytosis was measured by staining for the LAMP1 on the plasma membrane using 442 luminal epitope-specific anti-LAMP1 antibody. As expected, the cell surface expressions of LAMP1 in control 443 HeLa cells were found to be significantly increased upon ionomycin treatment (1.33% vs. 86%). In contrast, 444 cells stably expressing RNF167 showed a substantial reduction in the surface expression of LAMP1 compared 445 to the control cells under the same condition, 3.33 % as compared to 86% in control cells (Fig. 4A-B) . distinct cytosolic expression and also prevented the perinuclear clustering of lysosomes. This suggests that at-459 least; one of naturally occurring mutation in human tumors affects the lysosomal clustering ( Fig. 5B ). Since 460 lysosomal distribution is known to affect tumor progression and metastasis, we further investigated the effect of 461 these mutations on lysosomal exocytosis. Consistent with the results shown in Fig. 5 A and B , only K97N but 462 not other mutations or wild-type show a substantial increase in surface expression of LAMP1 ( Fig. 5C-D) . We further examined the effect of RNF167-K69N-mediated lysosomal exocytosis on the ability of cells to 473 reseal their plasma membrane. HeLa cells stably expressing the control vector or RNF167 or RNF167-K97N 474 were treated with acetate Ringer's solution (pH 6.9) for two hours followed by 200ng/ml Streptolysin-O (SLO) 475 for five minutes. SLO, a bacterial toxin, induces pore formation in the plasma membrane, and is commonly 476 used to study membrane resealing (34). Briefly, cells were allowed to reseal the damage by incubating them in 477 HBSS with or without Ca 2+ at 37°C for 10 minutes. The efficiency of resealing was measured by propidium 478 16 iodide (PI) staining as PI is impermeable to cells with the intact plasma membrane. As established earlier (42), 479 the percentage of PI staining in control cells upon Ca 2+ treatment was much less compared to those without Ca 2+ 480 confirming the requirement of Ca 2+ dependent lysosomal exocytosis for maintaining membrane integrity.
481
Consistent with lower LAMP1 surface expression ( Fig. 4A-B ), cells expressing RNF167 WT cells were unable 482 to repair the membrane resulting in a substantial increase in PI-positive cells, even in the presence of Ca 2+ , and 483 thus, emphasizing the importance of lysosomal exocytosis in maintaining plasma membrane integrity and its 484 regulation by RNF167 ( Fig.6A-B) . Importantly, cells expressing RNF167-K97N, a localization defective 485 mutant with more dispersed lysosomes was able to reseal the damage more effectively than wild-type 486 expressing cells, leading to lower PI staining ( Fig. 6C-D) . This enhanced resealing was found only in RNF167-487 K97N expressing cells but not in cells expressing other tumor-associated RNF167 mutants that were tested.
488
These ineffective mutants showed lysosomal clustering in the perinuclear region (Fig. 5A ). This suggests that 489 lysosomal exocytosis might represent an important way to confer a survival advantage to cancer cells, in 490 addition to other processes. Consistent with the above results, increased plasma membrane resealing in cells 491 expressing RNF167-K97N as compared to WT was also confirmed by FACS analysis (Fig. 6E ). with 5µM ionomycin at 37°C for 10 minutes after 2 hours of acetate Ringer's solution (pH 6.9) treatment. Cells 500 were immediately transferred to ice, stained with the luminal epitope-specific anti-LAMP1 antibody. As 501 expected, ionomycin treatment could not enhance the surface expression of LAMP1 in cells expressing 502 RNF167-a isoform; whereas the plasma membrane staining of LAMP1 in cells expressing RNF167-b isoform 503 exhibited a significant increase under the same experimental conditions.
505
We noticed about a 16 fold increase in surface expression of LAMP1 in cells stably expressing RNF167-b 506 isoform as compared to cells expressing RNF167-a isoform (Fig.7A-B ). Having found an increased surface 507 expression of LAMP1 in RNF167-b isoform expressing cells, we proceeded to measure the plasma membrane 508 resealing capacity by PI staining as described above. As expected, cells expressing RNF167-a isoform had a 509 strong impairment in plasma membrane resealing. In contrast, RNF167-b isoform expressing cells displayed an 510 17 efficient resealing, as assessed by low PI-positive cells in the presence of extracellular Ca 2+ (Fig.7C-D) .
511
RNF167-b isoform had about nine-fold less PI-positive cells when compared to cells expressing RNF167-a 512 isoform (9.66% PI-positive cells in b and 89% in a). These findings indicate that cells stably expressing 513 RNF167-b isoform has increased plasma membrane resealing by Ca 2+ dependent lysosomal exocytosis upon 514 extracellular acidification.
516
We also assessed the lysosomal exocytosis in HeLa cells transiently transfected with EYFP tagged RNF167-a 517 and RNF167-b. As expected, cells expressing RNF167-b-EYFP exhibited increased surface expression of 518 LAMP1 upon ionomycin treatment (Fig. S2.B ). This is in line with our finding that RNF167-b-EYFP 519 expressing cells have more dispersed lysosomes upon extracellular acidification. Collectively, our results 520 suggest that the two isoforms of RNF167 could affect tumor progression differently by promoting opposing 521 functions in the regulation of lysosomal positioning, exocytosis, and PMR. Lysosomes undergo long-range intracellular transport along microtubules with the help of motor proteins 526 kinesins and dynein and short-range transport via actin-based myosin motors (2). In this study, we show that 527 RNF167, a lysosomal associated ubiquitin ligase, regulates the intracellular movement of lysosomes. We found 528 that overexpression of RNF167 promotes dynein mediated retrograde transport of lysosomes whereas depletion 529 of endogenous RNF167 results in their anterograde movement. Our findings are further supported by the recent 530 observation that Arl8B, one of the key regulators of lysosomal anterograde movement, is a substrate for 531 RNF167 (24). We identified that the PA domain of RNF167 is required for its localization to the lysosomal 532 compartments and is essential for the perinuclear clustering of lysosomes. We further observed that RNF167 533 localizes to Rab7 positive endosomes in addition to lysosomes (data not shown) raising the possibility that 534 RNF167 can also affect conventional Rab7-RILP mediated retrograde movement of lysosomes along the 535 microtubules. It would be interesting to elucidate the role of RNF167 in recruiting dynein motors to lysosomes. (K97N, R200Q, C268R, R277L, and L329P ) that were tested, one mutation in the PA domain 548 (K97N) was unable to localize to lysosomes and to induce perinuclear clustering. This is consistent with the 549 observations shown in Fig. 2C with RNF167ΔPA , indicating the importance of lysosomal localization for 550 RNF167 function. To our surprise, RNF167-C268R, which harbor a missense mutation in the RING domain 551 still able to induce perinuclear clustering, unlike RNF167-C233S. RNF167-C233S, a ligase inactive mutant that 552 has been reported to block perinuclear clustering of lysosomes (24). To understand these differences, we 553 assessed the lysosomal association of C268R and C233S, two distinct ligase inactive mutants of RNF167 by 554 measuring the Pearson's coefficient. It was indeed evident from the Pearson's coefficient that C268R had a 555 better lysosomal association as compared to C233S (Fig. S2.A) . The differences in clustering may be attributed 556 to their intracellular localization or reasons yet to be found. In conclusion, ubiquitin ligase activity and the immunostaining using luminal epitope-specific anti-LAMP1 antibody) and PMR. K97N mutant was reported 575 from kidney tumor samples and the lysine residue at the 97 th position is highly conserved. The reason for 576 increased lysosomal exocytosis and PMR exhibited by K97N expressing cells is because of the dispersed 577 lysosomes compared to the WT expressing cells. The effect on lysosomal exocytosis is unique for K97N but not 578 for other mutations (C268R, R277L, and L32P) that have been tested. Also, K97N, not other mutants showed 579 defects in lysosomal localization. It is possible that these mutations of RNF167 can influence yet to be 580 discovered pathways without affecting lysosomal localization resulting in tumor progression. It would be 581 interesting to look at lysosomal positioning and exocytosis in primary cells derived from tumor samples of 582 patients with mutations in RNF167.
584
Interestingly, our findings also reveal an important role for RNF167 isoform. We found that isoform b results in 585 splicing of an exon that code for 1-35 amino acids, signal peptide. We demonstrated that signal peptide is also 586 required for lysosomal localization in addition to the PA domain as RNF167-b showed cytosolic localization.
587
We have confirmed the expression of RNF167-b in COLO-205 cells by sequencing the amplified PCR 588 products. Moreover, we found that RNF167-b, unlike RNF167-a, enhances lysosomal exocytosis and PMR. We 589 provide evidence for functional differences between the two variants. Differential expression of isoforms with 590 antagonistic functions has been associated with tumor progression. For example, Intersectin1 (ITSN1) is a 591 highly conserved scaffold protein and exists in two isoforms referred to as long isoform (ITSN1-L) and short 592 isoform (ITSN1-S). ITSN1-S promotes glioma development whereas ITSN1-L inhibits glioma progression both 593 in vivo and in vitro. This opposing function of ITSN1-S and ITSN1-L is highly regulated by alternative splicing 594 (44). Similarly, alternative splicing of CD99 leads to two isoforms, full-length (CD99wt) and a truncated short 595 form (CD99sh) (45, 46) . CD99 is a transmembrane glycoprotein that plays a crucial role in cell adhesion, Hence it is conceivable that isoforms of RNF167 could also play a major role in maintaining homeostasis at the 603 organism level. In summary, our study identifies RNF167 as an important regulator in Ca 2+ dependent 604 lysosomal exocytosis and plasma membrane resealing. We demonstrated that K97N, one of the tumor-605 associated mutants of RNF167 is unable to localize to the lysosomal compartments and cells expressing this 606 20 mutant efficiently repair the plasma membrane by enhanced lysosomal exocytosis. We also show that a 607 localization defective variant of RNF167, isoform b, lacking 1-35 amino acids, also failed to cluster lysosomes 608 in the perinuclear region and shows similar phenotype as K97N. Our data reveal new clues for the regulation of 609 lysosomal exocytosis and tumor progression. wild-type and variants were treated with acetate Ringer's solution (pH 6.9) for two hours. These cells were 787 stained with antibodies specific for LAMP1 and GFP and images were acquired using confocal microscopy. D) 788 Quantification of lysosomal distribution was done by calculating PNI (n=3, 15-20 cells per experiment). Data 789 represent mean ± SEM. Statistical significance was calculated using one-way ANOVA followed by Tukey's 790 multiple comparison test to compare the means of each sample (****P<0.0001). was quantified at 0-5 µm, 5-15 µm, and >15 µm. Statistical significance (in B and C) was calculated using one-798 26 way ANOVA followed by Tukey's multiple comparison test (n=3, 30 cells per experiment, *P<0.05, ** P<0.01, 799 ***P<0.001, ns-not significant). D) HeLa cells co-transfected with RNF167-2X FLAG and GFP/Dynamitin-800 GFP were fixed after acetate Ringer's solution (pH 6.9) treatment and immunostained with antibodies specific 801 for LAMP1 and FLAG. E) HeLa cells transfected with RNF167-2X FLAG and treated with acetate Ringer's 802 solution (pH 6.9) and 50μM Ciliobrevin D. Immunostaining was performed as in D. All data shown are mean ± 803 SEM. Scale bars, 5 µm. shown are mean ± SEM. Statistical significance was verified using two-way ANOVA followed by Tukey's 813 multiple comparison test (****P<0.0001, ns-not significant). wild-type or tumor-associated mutants were treated with acetate Ringer's solution (pH 6.9) for two hours. These 817 cells were fixed and immunostained with antibodies specific for LAMP1 and GFP. B) Quantification of 818 lysosomal distribution was done by measuring PNI (n=3, 15-18 cells per experiment). Statistical significance 819 was verified using one-way ANOVA, followed by Tukey's multiple comparison test (*P<0.05, ****P<0.0001, 820 ns-not significant). C) HeLa cells stably expressing RNF167 wild-type or tumor-associated mutants were 821 treated with acetate Ringer's solution (pH 6.9) for two hours followed by 5μM ionomycin for 10 minutes at 822 37°C. The presence of LAMP1 on the plasma membrane was detected using luminal epitope-specific anti-823 LAMP1 antibody. D) Quantification of surface expression of LAMP1 described in C. A minimum of 180 cells 824 was counted from three independent experiments and the statistical significance was calculated using two-way 825 ANOVA followed by Tukey's multiple comparison test (****P<0.0001, ns-not significant). All data shown are 826 mean ± SEM. Scale bars, 5μm. acetate Ringer's solution (pH 6.9) for two hours followed by 200 ng/ml streptolysin-O (SLO) for five minutes 831 on ice and allowed to reseal in the presence or absence of Ca 2+ . B) Quantification of percentage PI-positive cells 832 described in A. A minimum of 5500 cells was enumerated from three independent experiments and the 833 statistical significance was calculated using two-way ANOVA followed by Tukey's multiple comparison test 834 (*P<0.05, ****P<0.0001, ns-not significant). C) Confocal images of PI stained HeLa cells stably expressing 835 RNF167 wild-type or tumor-associated mutants were treated as mentioned in A. D) Quantification of 836 percentage PI-positive cells described in C. A minimum of 2400 cells was counted from three independent 837 experiments. Statistical significance was calculated using two-way ANOVA followed by Tukey's multiple 838 comparison test (*P<0.05, ****P<0.0001, ns-not significant). E) Percentage of plasma membrane resealing 839 (PMR) in HeLa cells stably expressing empty vector, or RNF167 wild-type, or K97N. Cells were treated as 840 described in A and PI-positive cells were measured by flow cytometry (n=5, 10,000 events were analyzed per 841 experiment). Statistical significance was verified by one-way ANOVA followed by Tukey's multiple 842 comparison test (* P<0.05). All data shown are mean ± SEM. Scale bars, 10 µm. RNF167-a or RNF167-b were treated with acetate Ringer's solution (pH 6.9) for two hours followed by 5 µM 846 ionomycin for 10 minutes at 37°C. Cells were stained with luminal epitope-specific anti-LAMP1 for 30 minutes 847 on ice. B) Quantification of surface expression of LAMP1 described in A. A minimum of 70 cells was counted 848 per experiment (n=3). Scale bar-5μm. C) HeLa cells stably expressing either RNF167-a or RNF167-b were 849 treated with acetate Ringer's solution (pH 6.9) for two hours followed by 200 ng/ml SLO for 5 minutes on ice.
850
These cells were allowed to reseal the damage in the presence or absence of Ca 2+ . D) Quantification of PI-851 positive cells from merged images of HeLa cells stained with DAPI and PI after the SLO treatment. A 852 minimum of 3200 cells was counted from three independent experiments. All data shown are mean ± SEM and 853 the statistical significance was verified using two-way ANOVA followed by Tukey's multiple comparison test 854 (****P<0.0001, ns-not significant). Scale bar, 10 µm. 
